{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:29:13Z","timestamp":1793964553812,"version":"4.8.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":260,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008867","name":"Department of Education of Zhejiang Province","doi-asserted-by":"publisher","award":["Y202351295"],"award-info":[{"award-number":["Y202351295"]}],"id":[{"id":"10.13039\/501100008867","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004835","name":"Zhejiang University","doi-asserted-by":"publisher","award":["2023-KYY-518053-0090"],"award-info":[{"award-number":["2023-KYY-518053-0090"]}],"id":[{"id":"10.13039\/501100004835","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.clinsp.2026.101163","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:04:01Z","timestamp":1790121841000},"page":"101163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Lipids, lipid-modifying drug targets with venous thromboembolism: a mendelian randomization study"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6555-5961","authenticated-orcid":false,"given":"Liuyan","family":"Nie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4948-3114","authenticated-orcid":false,"given":"Yongmei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1091-2367","authenticated-orcid":false,"given":"Fenping","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clinsp.2026.101163_bib0001","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41569-022-00787-6","article-title":"Epidemiology and prevention of venous thromboembolism","volume":"20","author":"Lutsey","year":"2023","journal-title":"Nat Rev Cardiol"},{"issue":"10294","key":"10.1016\/j.clinsp.2026.101163_bib0002","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(20)32658-1","article-title":"Venous thromboembolism","volume":"398","author":"Khan","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.clinsp.2026.101163_bib0003","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.thromres.2017.06.017","article-title":"Late outcomes of pulmonary embolism: the post-PE syndrome","volume":"164","author":"Sista","year":"2018","journal-title":"Thromb Res"},{"issue":"19","key":"10.1016\/j.clinsp.2026.101163_bib0004","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.clinsp.2026.101163_bib0005","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE Disease: CHEST guideline and expert panel report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.clinsp.2026.101163_bib0006","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1161\/CIRCRESAHA.121.318225","article-title":"Inflammation, infection and venous thromboembolism","volume":"128","author":"Colling","year":"2021","journal-title":"Circ Res"},{"issue":"15","key":"10.1016\/j.clinsp.2026.101163_bib0007","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1001\/jama.2018.14346","article-title":"Venous thromboembolism: advances in diagnosis and treatment","volume":"320","author":"Tritschler","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.clinsp.2026.101163_bib0008","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.clinsp.2026.101163_bib0009","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/S2352-3026(16)30184-3","article-title":"Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis","volume":"4","author":"Kunutsor","year":"2017","journal-title":"Lancet Haematol"},{"issue":"20","key":"10.1016\/j.clinsp.2026.101163_bib0010","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1093\/eurheartj\/ehx107","article-title":"Statins and secondary prevention of venous thromboembolism: pooled analysis of published observational cohort studies","volume":"38","author":"Kunutsor","year":"2017","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.clinsp.2026.101163_bib0011","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/eurheartj\/ehp556","article-title":"Statins, fibrates, and venous thromboembolism: a meta-analysis","volume":"31","author":"Squizzato","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinsp.2026.101163_bib0012","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1477-9560-12-26","article-title":"Influence of statin use on the incidence of recurrent venous thromboembolism and major bleeding in patients receiving rivaroxaban or standard anticoagulant therapy","volume":"12","author":"Wells","year":"2014","journal-title":"Thromb J"},{"key":"10.1016\/j.clinsp.2026.101163_bib0013","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejim.2019.07.028","article-title":"Statin and all-cause mortality in patients receiving anticoagulant therapy for venous thromboembolism. Data from the RIETE registry","volume":"68","author":"Siniscalchi","year":"2019","journal-title":"Eur J Intern Med"},{"issue":"2","key":"10.1016\/j.clinsp.2026.101163_bib0014","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1161\/01.ATV.0000151647.14923.ec","article-title":"Statins and blood coagulation","volume":"25","author":"Undas","year":"2005","journal-title":"Arter Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.clinsp.2026.101163_bib0015","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.286.1.64","article-title":"Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation\/CRP evaluation (PRINCE): a randomized trial and cohort study","volume":"286","author":"Albert","year":"2001","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.clinsp.2026.101163_bib0016","doi-asserted-by":"crossref","first-page":"131","DOI":"10.7326\/M17-0291","article-title":"Diagnosis of venous thromboembolism: 20 years of progress","volume":"168","author":"Wells","year":"2018","journal-title":"Ann Intern Med"},{"issue":"18","key":"10.1016\/j.clinsp.2026.101163_bib0017","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1136\/heartjnl-2016-310605","article-title":"Mendelian randomisation in cardiovascular research: an introduction for clinicians","volume":"103","author":"Bennett","year":"2017","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.clinsp.2026.101163_bib0018","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1038\/s41467-020-16969-0","article-title":"Genetic drug target validation using mendelian randomisation","volume":"11","author":"Schmidt","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.clinsp.2026.101163_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104543","article-title":"Genetic association of lipids and lipid-lowering drug target genes with non-alcoholic fatty liver disease","volume":"90","author":"Li","year":"2023","journal-title":"EBioMedicine"},{"issue":"10","key":"10.1016\/j.clinsp.2026.101163_bib0020","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/s41576-021-00387-z","article-title":"Advancing the use of genome-wide association studies for drug repurposing","volume":"22","author":"Reay","year":"2021","journal-title":"Nat Rev Genet"},{"issue":"4","key":"10.1016\/j.clinsp.2026.101163_bib0021","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/CIRCULATIONAHA.118.038814","article-title":"Use of genetic variants related to antihypertensive drugs to inform on efficacy and side effects","volume":"140","author":"Gill","year":"2019","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.clinsp.2026.101163_bib0022","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/CIRCULATIONAHA.119.040180","article-title":"Novel drug targets for ischemic stroke identified through mendelian randomization analysis of the blood proteome","volume":"140","author":"Chong","year":"2019","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.clinsp.2026.101163_bib0023","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41588-020-00773-z","article-title":"Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer\u2019s disease pathogenesis","volume":"53","author":"Wingo","year":"2021","journal-title":"Nat Genet"},{"issue":"51","key":"10.1016\/j.clinsp.2026.101163_bib0024","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000040770","article-title":"Genetic correlation between genes targeted by lipid-lowering drugs and venous thromboembolism: a drug-target mendelian randomization study","volume":"103","author":"Li","year":"2024","journal-title":"Medicine"},{"issue":"16","key":"10.1016\/j.clinsp.2026.101163_bib0025","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR Statement","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.clinsp.2026.101163_bib0026","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng.2797","article-title":"Discovery and refinement of loci associated with lipid levels","volume":"45","author":"Willer","year":"2013","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.clinsp.2026.101163_bib0027","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.clinsp.2026.101163_bib0028","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/CIRCGENETICS.114.000952","article-title":"CARDIoGRAMplusC4D Consortium, Stewart AFR, et al. Effect of bile acid sequestrants on the risk of cardiovascular events: a mendelian randomization analysis","volume":"8","author":"Ross","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"issue":"9943","key":"10.1016\/j.clinsp.2026.101163_bib0029","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(14)61009-6","article-title":"LDL cholesterol: controversies and future therapeutic directions","volume":"384","author":"Ridker","year":"2014","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.clinsp.2026.101163_bib0030","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41569-022-00676-y","article-title":"Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia","volume":"19","author":"Bor\u00e9n","year":"2022","journal-title":"Nat Rev Cardiol"},{"issue":"6509","key":"10.1016\/j.clinsp.2026.101163_bib0031","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.aaz1776","article-title":"The GTEx Consortium atlas of genetic regulatory effects across human tissues","volume":"369","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.clinsp.2026.101163_bib0032","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s42003-023-05279-y","article-title":"Transcriptome-wide association studies: recent advances in methods, applications and available databases","volume":"6","author":"Mai","year":"2023","journal-title":"Commun Biol"},{"issue":"9822","key":"10.1016\/j.clinsp.2026.101163_bib0033","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(12)60404-8","article-title":"What makes UK Biobank special?","volume":"379","author":"Collins","year":"2012","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.clinsp.2026.101163_bib0034","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ng.3538","article-title":"Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets","volume":"48","author":"Zhu","year":"2016","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.clinsp.2026.101163_bib0035","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1001\/jamapsychiatry.2021.0005","article-title":"Association of antihypertensive drug target genes with psychiatric disorders: a mendelian randomization study","volume":"78","author":"Chauquet","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.clinsp.2026.101163_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104494","article-title":"Therapeutic targets for inflammatory bowel disease: proteome-wide mendelian randomization and colocalization analyses","volume":"89","author":"Chen","year":"2023","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.clinsp.2026.101163_bib0037","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1172\/JCI116582","article-title":"The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high-density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis","volume":"92","author":"Tsutsumi","year":"1993","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.clinsp.2026.101163_bib0038","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.bmcl.2014.03.021","article-title":"A novel lipoprotein lipase (LPL) agonist rescues the enzyme from inhibition by angiopoietin-like 4 (ANGPTL4)","volume":"24","author":"Geldenhuys","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"issue":"2","key":"10.1016\/j.clinsp.2026.101163_bib0039","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.bbrc.2014.06.114","article-title":"Identification of a small molecule that stabilizes lipoprotein lipase in vitro and lowers triglycerides in vivo","volume":"450","author":"Larsson","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1016\/j.clinsp.2026.101163_bib0040","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/abbs\/gmx038","article-title":"Apelin-13 inhibits lipoprotein lipase expression via the APJ\/PKC\u03b1\/miR-361-5p signaling pathway in THP-1 macrophage-derived foam cells","volume":"49","author":"Zhang","year":"2017","journal-title":"Acta Biochim Biophys Sin"},{"issue":"5","key":"10.1016\/j.clinsp.2026.101163_bib0041","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1073\/pnas.0538015100","article-title":"Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: evidence for an antiinflammatory role for lipoprotein lipase","volume":"100","author":"Ziouzenkova","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.clinsp.2026.101163_bib0042","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.drudis.2016.10.007","article-title":"Emerging strategies of targeting lipoprotein lipase for metabolic and cardiovascular diseases","volume":"22","author":"Geldenhuys","year":"2017","journal-title":"Drug Discov Today"},{"issue":"12","key":"10.1016\/j.clinsp.2026.101163_bib0043","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.119.002711","article-title":"Genetic determinants of lipids and cardiovascular disease outcomes: a wide-angled mendelian randomization investigation","volume":"12","author":"Allara","year":"2019","journal-title":"Circ Genom Precis Med"},{"issue":"3","key":"10.1016\/j.clinsp.2026.101163_bib0044","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41588-022-01286-7","article-title":"Genome-wide meta-analysis identifies 93 risk loci and enables risk prediction equivalent to monogenic forms of venous thromboembolism","volume":"55","author":"Ghouse","year":"2023","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.clinsp.2026.101163_bib0045","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ehj.2003.11.004","article-title":"Tissue plasminogen activator antigen and coronary heart disease. Prospective study and meta-analysis","volume":"25","author":"Lowe","year":"2004","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.clinsp.2026.101163_bib0046","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41569-020-00493-1","article-title":"Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development","volume":"18","author":"Holmes","year":"2021","journal-title":"Nat Rev Cardiol"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593226002905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593226002905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:16:54Z","timestamp":1793963814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593226002905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":46,"alternative-id":["S1807593226002905"],"URL":"https:\/\/doi.org\/10.1016\/j.clinsp.2026.101163","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipids, lipid-modifying drug targets with venous thromboembolism: a mendelian randomization study","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinsp.2026.101163","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 HCFMUSP. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101163"}}